Ginlix AI
50% OFF

Technical Indicator Analysis of Canbridge Pharmaceuticals (1228.HK)

#technical_analysis #stock_investment #overbought_oversold #rsi #kdj #macd #bollinger_bands #hk_stocks
Neutral
A-Share
January 6, 2026

Unlock More Features

Login to access AI-powered analysis, deep research reports and more advanced features

Technical Indicator Analysis of Canbridge Pharmaceuticals (1228.HK)

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.

Related Stocks

1228.HK
--
1228.HK
--
Technical Indicator Analysis of Canbridge Pharmaceuticals (1228.HK)

Based on the latest data analysis, the technical indicators of Canbridge Pharmaceuticals

do not show the existence of an overbought signal currently
. The following is a detailed analysis:


1. Current Status of Core Technical Indicators
Indicator Current Value Status
RSI(14)
44.78 ✅ Normal range (30-70)
KDJ - K Value
26.92 ✅ Normal range
MACD
-0.0118 📉 Negative value, weak
Bollinger Band Position
0.22 📊 Close to lower band

2. Overbought/Oversold Signal Analysis
1. RSI Indicator Analysis
  • Current RSI = 44.78
    , which is within the normal range and far from the overbought area above 70
  • Annual RSI change trajectory
    :
    • Annual highest RSI: 92.50 (once entered the overbought area)
    • Annual lowest RSI:1.69 (severely oversold)
    • Average RSI:42.51
  • RSI trend in the last 30 days
    : rose from 19.87 to 44.78, a rebound of about 25 points, indicating gradual recovery from the oversold area
2. KDJ Indicator Analysis
  • K value =26.92, D value=17.43
    , both within the normal range of 20-80
  • Did not reach the overbought threshold above 80
3. Bollinger Band Analysis
  • Bollinger Band position=0.22
    (0=lower band,1=upper band)
  • The stock price moves close to the lower band, indicating that it is currently in a relatively weak area

3. Key Findings
  1. No overbought risk currently
    : Although you mentioned a full-year increase of 1824%, as of January 6, 2025, the latest closing price is $0.134, which has fallen sharply from the annual high [0]

  2. Weak technical signal
    : MACD is negative, and the stock price is below the 50-day moving average ($0.18), indicating that the medium-term trend remains weak [0]

  3. Risk reminder
    : Although there is no overbought currently, this stock has extremely high volatility (RSI annual fluctuation range:1.69-92.50), and investors need to pay attention to risks


4. Conclusion

Current technical indicators do not show an overbought signal
. On the contrary, after experiencing severe fluctuations, this stock is gradually rebounding from the oversold area. RSI, KDJ, and Bollinger Bands all show that the stock price is in a relatively reasonable range, but the medium-term trend remains weak; it is recommended that investors pay close attention to subsequent trends.

Canbridge Pharmaceuticals Technical Analysis Chart


References

[0] Gilin AI Brokerage API Data - Technical Analysis Data of Canbridge Pharmaceuticals (1228.HK)

Related Reading Recommendations
No recommended articles
Ask based on this news for deep analysis...
Alpha Deep Research
Auto Accept Plan

Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.